Current Cancer Drug Targets

Editor-in-Chief

Ruiwen Zhang
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204
(USA)

Personal Subscription
Become EABM
Become Reviewer

Mammalian Target of Rapamycin (mTOR) Inhibitors as Anti-Cancer Agents

Volume:4   Issue: 8
Pp: 621-635
Ravi D. Rao, Jan C. Buckner and Jann N. Sarkaria
DOI: 10.2174/1568009043332718

Targeting the STAT Pathway in Head and Neck Cancer: Recent Advances and Future Prospects

Volume:4   Issue: 8
Pp: 637-651
N. G. Nikitakis, H. Siavash and J. J. Sauk
DOI: 10.2174/1568009043332736

Wnt / β-Catenin Signaling Pathway as Novel Cancer Drug Targets

Volume:4   Issue: 8
Pp: 653-671
Hue H. Luu, Ruiwen Zhang, Rex C. Haydon, Elizabeth Rayburn, Quan Kang, Weike Si, Jong Kyung Park, Hui Wang, Ying Peng, Wei Jiang and Tong- Chuan He
DOI: 10.2174/1568009043332709

Bacteria and Bacterial Toxins as Therapeutic Agents for Solid Tumors

Volume:4   Issue: 8
Pp: 689-702
P. Michl and T. M. Gress
DOI: 10.2174/1568009043332727